During the past decade, Sutter Health - Western Division Cancer Research Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Health - Western Division Cancer Research Group" #1 sponsor was "Radiation Therapy Oncology Group" with 43 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "NSABP Foundation Inc" with 7 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored and "Alliance for Clinical Trials in Oncology" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Health - Western Division Cancer Research Group" #1 collaborator was "National Cancer Institute (NCI)" with 66 trials as a collaborator, "Eastern Cooperative Oncology Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Health - Western Division Cancer Research Group" are "Prostate Cancer" (11 trials), "Breast Cancer" (10 trials), "Head and Neck Cancer" (9 trials), "Lung Cancer" (7 trials) and "Metastatic Cancer" (5 trials). Many other conditions were trialed in "Sutter Health - Western Division Cancer Research Group" in a lesser frequency.

Most popular intervention types in "Sutter Health - Western Division Cancer Research Group" are "Drug" (55 trials), "Radiation" (43 trials), "Procedure" (18 trials), "Biological" (15 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (33 trials), "cisplatin" (12 trials), "conventional surgery" (10 trials), "paclitaxel" (10 trials) and "filgrastim" (6 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Health - Western Division Cancer Research Group" are 49 trials for "All" genders, 12 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Health - Western Division Cancer Research Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Sutter Health - Western Division Cancer Research Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Health - Western Division Cancer Research Group, 10 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".